EDGAR·FLOW

OneMedNet Corp — Form 8-K

Filed November 6, 2026 · analyzed by the 8-K Agent
8-K ▲ Likely positive significance 78/100
What the filing says
OneMedNet reported preliminary Q3 2026 revenue of approximately $1 million, representing 242% sequential growth from Q2 2026 ($0.41M implied) and 465% year-over-year growth from Q3 2025 ($0.19M implied). The company provided Q4 2026 revenue guidance of $12–14 million, pending customer acceptance. This revenue acceleration follows the company's scaling of its de-identification pipeline and delivery infrastructure during 2026.
Why this rating

Q4 guidance of $12–14M annualizes to $48–56M, roughly 3.5–4x current market cap; validates multi-year growth narrative and execution risk mitigation through actual delivery.

Tradability signal
NO TRADE

No trade: price $0.01 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
at our read · unknown
$0.01
+10 min · unknown
$0.01 ▲ 0.00%
+30 min · unknown
$0.01 ▲ 0.00%
+1 hr · unknown
$0.01 ▲ 0.00%
+4 hrs · unknown
$0.01 ▲ 0.00%

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ ONMDW · stock on Yahoo Finance ↗

See more from November 6, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.